EP3638307A4 - STABLE BREAST MILK ANTIBODIES FOR ORAL ADMINISTRATION - Google Patents

STABLE BREAST MILK ANTIBODIES FOR ORAL ADMINISTRATION Download PDF

Info

Publication number
EP3638307A4
EP3638307A4 EP18817201.9A EP18817201A EP3638307A4 EP 3638307 A4 EP3638307 A4 EP 3638307A4 EP 18817201 A EP18817201 A EP 18817201A EP 3638307 A4 EP3638307 A4 EP 3638307A4
Authority
EP
European Patent Office
Prior art keywords
breastmilk
antibodies
oral delivery
pooled
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18817201.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3638307A1 (en
Inventor
Viraj MANE
Rikin MEHTA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LACTIGA US, INC.
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3638307A1 publication Critical patent/EP3638307A1/en
Publication of EP3638307A4 publication Critical patent/EP3638307A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP18817201.9A 2017-06-13 2018-06-12 STABLE BREAST MILK ANTIBODIES FOR ORAL ADMINISTRATION Pending EP3638307A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762518631P 2017-06-13 2017-06-13
PCT/CA2018/050703 WO2018227285A1 (en) 2017-06-13 2018-06-12 Stable pooled breastmilk antibodies for oral delivery

Publications (2)

Publication Number Publication Date
EP3638307A1 EP3638307A1 (en) 2020-04-22
EP3638307A4 true EP3638307A4 (en) 2021-03-10

Family

ID=64658795

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18817201.9A Pending EP3638307A4 (en) 2017-06-13 2018-06-12 STABLE BREAST MILK ANTIBODIES FOR ORAL ADMINISTRATION

Country Status (5)

Country Link
US (1) US11124560B2 (ja)
EP (1) EP3638307A4 (ja)
JP (1) JP6903774B2 (ja)
CA (1) CA3037383C (ja)
WO (1) WO2018227285A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111676268B (zh) * 2020-06-30 2024-01-30 李达 一种母乳α-淀粉酶活性检测方法
WO2022243979A1 (en) * 2021-05-20 2022-11-24 Lactiga, Inc. Polyclonal antibodies to treat respiratory syncytial virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120213796A1 (en) * 2011-02-22 2012-08-23 Fox Barbara S Polyclonal antibody compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0404861B8 (pt) * 2004-11-05 2021-05-25 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp método de extração da imunoglobulina a secretória (siga) a partir do leite materno e colostro humano e seu uso clínico por via oral
EP2854848B1 (en) 2012-05-25 2016-10-26 Gottfried Himmler Secretory immunoglobulin deficiency treatment and prophylaxis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120213796A1 (en) * 2011-02-22 2012-08-23 Fox Barbara S Polyclonal antibody compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WINGFIELD: "Protein Precipitation Using Ammonium Sulfate", CURRENT PROTOCOLS IN PROTEIN SCIENCE, vol. 84, no. 1, 1 April 2016 (2016-04-01), US, XP055769290, ISSN: 1934-3655, DOI: 10.1002/0471140864.psa03fs84 *

Also Published As

Publication number Publication date
WO2018227285A1 (en) 2018-12-20
US11124560B2 (en) 2021-09-21
US20200123232A1 (en) 2020-04-23
EP3638307A1 (en) 2020-04-22
CA3037383A1 (en) 2018-12-20
CA3037383C (en) 2020-03-24
JP6903774B2 (ja) 2021-07-14
JP2020523403A (ja) 2020-08-06

Similar Documents

Publication Publication Date Title
EP3247439B8 (en) Nasal/oral cannula system
EP3463228A4 (en) INTRAOCULAR ADMINISTRATION OF MEDICINES
EP3629765A4 (en) DOSAGE DELIVERY FILM
EP3373861A4 (en) IMPLANT SUPPLY CAPSULE
EP3294212A4 (en) DRUG DELIVERY FROM HYDROGEL
EP3374004A4 (en) ADJUSTMENT OF INSULIN DELIVERY RATES
EP3367979A4 (en) Implant delivery capsule
EP3355801A4 (en) PERSONALIZED INTRA-AURICULAR DRUG DELIVERY APPARATUS
EP3302265A4 (en) Drug delivery capsule
EP3265064A4 (en) Drug delivery device
PT3762009T (pt) Construções de administração derivadas de toxinas para administração oral
EP3125943A4 (en) Phosphate based linkers for intracellular delivery of drug conjugates
EP3870263A4 (en) DISPENSING DEVICE
EP3128961A4 (en) Implant delivery system
EP3565502A4 (en) ORAL IRRIGATOR
EP3698146A4 (en) REAGENT DISTRIBUTION SYSTEM
EP3638335A4 (en) BREAST MILK PUMP
EP3593851A4 (en) CATHETER RELEASE DEVICE
EP3437623A4 (en) GLASS POWDER FOR DENTAL USE
EP3643353A4 (en) DRUG DELIVERY ROBOT
IL277209A (en) Structures for administration of toxin derivatives for oral administration
EP3682016A4 (en) FORMULATIONS FOR ADMINISTERING COMPOUNDS
EP3845203A4 (en) LAYING DEVICE
EP3773730A4 (en) Drug delivery formulations
EP3773362A4 (en) MEDICAL DEVICE PLACEMENT

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210209

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/17 20160101ALI20210203BHEP

Ipc: A23J 1/20 20060101ALI20210203BHEP

Ipc: C07K 1/30 20060101ALI20210203BHEP

Ipc: A61K 39/395 20060101AFI20210203BHEP

Ipc: C07K 16/04 20060101ALI20210203BHEP

Ipc: A23K 20/142 20160101ALI20210203BHEP

Ipc: A23L 33/19 20160101ALI20210203BHEP

Ipc: A61P 37/00 20060101ALI20210203BHEP

Ipc: A61K 35/20 20060101ALI20210203BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210930

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20231109

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LACTIGA, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LACTIGA, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LACTIGA US, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LACTIGA US, INC.